A previous study identified ZHX2 as a VHL target upregulated in VHL mutant ccRCC tumors and showed that ZHX2 is essential for VHL mutant ccRCC cell growth in vitro and in vivo (32). Here, VHL is linked to nonpapillary renal cell carcinoma.